Home › NDC Lookup › RxCUI directory › RxCUI 2705400

1 ML ustekinumab-aekn 90 MG/ML Prefilled Syringe — RxCUI 2705400

RxNorm drug concept · Semantic clinical drug
RxCUI 2705400 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2705400
Official name1 ML ustekinumab-aekn 90 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asustekinumab-aekn 90 MG per 1 ML Prefilled Syringe; ustekinumab-aekn 90 MG in 1 ML Prefilled Syringe; ustekinumab-aekn 90 MG/ML per 1 ML Prefilled Syringe
FDA products mapped8
Package NDCs mapped9
Reported Medicaid activity (SDUD)1,800 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ustekinumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ustekinumab is approved to treat moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn's disease, and moderately to severely active u...
  • What conditions does ustekinumab treat, and is it right for me?
  • It depends on your condition. For Crohn's disease and ulcerative colitis, the first dose is given as an IV infusion in a clinical setting. After that, you switch to under-the-skin...
  • How is ustekinumab given, and will I need to go to a clinic every time?
📖 Read our full Ustekinumab Injection guide →

🕸️ Concept Web — How 1 ML ustekinumab-aekn 90 MG/ML Prefilled Syringe Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML ustekinumab-aekn 90 MG/ML Prefilled Syringe RxCUI 2705400

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ustekinumab 847083
    • Ustekinumab-aekn 2705377
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Selarsdi 2705384
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ustekinumab Prefilled Syringe 853349
    • Ustekinumab-aekn Prefilled Syringe 2705392
    • Ustekinumab Injectable Product 1163983
    • Ustekinumab-aekn Injectable Product 2705380
    • Ustekinumab Prefilled Syringe [Selarsdi] 2705396
    • Ustekinumab-aekn Prefilled Syringe [Selarsdi] 2705397
    • Selarsdi Injectable Product 2705386
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ustekinumab-aekn 90 MG/ML SCDC · 2705391
  • Ustekinumab Prefilled Syringe SCDF · 853349
  • Ustekinumab-aekn Prefilled Syringe SCDFP · 2705392
  • Ustekinumab Injectable Product SCDG · 1163983
  • Ustekinumab-aekn Injectable Product SCDGP · 2705380

Brand-Name Concepts

  • 1 ML ustekinumab-aekn 90 MG/ML Prefilled Syringe [Selarsdi] SBD · 2705401
  • Ustekinumab-aekn 90 MG/ML [Selarsdi] SBDC · 2705395
  • Ustekinumab Prefilled Syringe [Selarsdi] SBDF · 2705396
  • Ustekinumab-aekn Prefilled Syringe [Selarsdi] SBDFP · 2705397
  • Selarsdi Injectable Product SBDG · 2705386
  • Selarsdi BN · 2705384

📦 FDA Products & Package NDCs

8 products · 9 package NDCs
9 package NDCs map to RxCUI 2705400 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50090-7769-00 1 TRAY in 1 CARTON (50090-7769-0) / 1 mL in 1 TRAY SELARSDI A-S Medication Solutions 2025-11-17
51759-0413-32 1 TRAY in 1 CARTON (51759-413-32) / 1 SYRINGE, GLASS in 1 T... Ustekinumab-aekn Teva Pharmaceuticals USA, Inc. 2025-12-23
51759-0414-32 1 TRAY in 1 CARTON (51759-414-32) / 1 SYRINGE, GLASS in 1 T... Ustekinumab-aekn Teva Pharmaceuticals USA, Inc. 2025-12-23
51759-0505-13 1 VIAL in 1 CARTON (51759-505-13) / .5 mL in 1 VIAL Selarsdi Teva Pharmaceuticals USA, Inc. 2025-10-16
51759-0505-32 1 TRAY in 1 CARTON (51759-505-32) / 1 SYRINGE, GLASS in 1 T... Selarsdi Teva Pharmaceuticals USA, Inc. 2025-03-12
51759-0607-32 1 TRAY in 1 CARTON (51759-607-32) / 1 SYRINGE, GLASS in 1 T... Selarsdi Teva Pharmaceuticals USA, Inc. 2025-03-12
51759-0708-13 1 VIAL, GLASS in 1 CARTON (51759-708-13) / 26 mL in 1 VIAL,... Selarsdi Teva Pharmaceuticals USA, Inc. 2025-03-12
51759-0709-32 1 TRAY in 1 CARTON (51759-709-32) / 1 SYRINGE, GLASS in 1 T... Ustekinumab-aekn Teva Pharmaceuticals USA, Inc. 2025-06-02
51759-0710-32 1 TRAY in 1 CARTON (51759-710-32) / 1 SYRINGE, GLASS in 1 T... Ustekinumab-aekn Teva Pharmaceuticals USA, Inc. 2025-06-02
Observed labelers: Teva Pharmaceuticals USA, Inc. (8) · A-S Medication Solutions (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
Q9998 Inj ustekinumab-aekn, 1 mg 8 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.